Meerut News: CCS University Receives 113 Applications for 100 Seats, Merit List to Be Released on Sunday

Meerut News

Meerut News: The first-ever B Pharma course at Chaudhary Charan Singh University has received positive feedback from students. For the 100 available slots, 113 applications have been received. On Sunday, the university will announce the cutoff for this course. At the same time, Meerut College began accepting LLB registrations on Friday. For the college’s 300 available seats, 112 applications were received on the first day. The first aided college to begin accepting applications for LLB students is Meerut College. The letter of acknowledgment from BCI has not yet been sent to NAS, MMH, or NERG colleges.

Academic Updates and PhD Admissions at Chaudhary Charan Singh University

The results of the B.Ed Final exams for more than 30.000 students have been made public by the university. Only 26 colleges’ results have been withheld since there are no practical marks available. The results of the BA-LLB 10th Sem and the 9th Sem of the MSc in Botany, Chemistry, Physics, Statistics, Mathematics, and Zoology have also been made public. From today, all of the aforementioned findings, along with the challenge evaluation, are available on the university website. The second list of applicants for PhD in Education admission has been made public by the university. Students on the list are required to show up at the campus research office by September 4. More details are available to students on the university website.

First-Year Graduation Enrollment and Offer Letter Submission Details

Registration for available spots in the university’s associated institutions’ first-year graduation began on Friday. By September 4, students can enrol. By September 5, they must submit the completed offer letter to any college and course. Students who have already registered may also submit their offer letter up to that time.

Keep watching our YouTube Channel ‘DNP INDIA’. Also, please subscribe and follow us on FACEBOOKINSTAGRAMand TWITTER.

Exit mobile version